What does BRM stand for?

Business Review Meeting

This definition appears very rarely and is found in the following Acronym Finder categories:

Military and Government
Business, finance, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Building Repair & Maintenance Business Process Redesign Methodology Business Rate Multiplier (UK) Business Records Management, Inc (Pennsylvania) Business Reference Model (Federal Enterprise Architecture) Business Regional Manager Business Relationship Management Business Reply Mail Business Research Method Business Resource Management		Business Risk Management Business Road Map Business Rule Management B Reactor Museum Association (Richland, WA) Blue Ribbon Mentor Advocates (Chapel Hill, NC) Boca Raton Museum of Art (Boca Raton, FL) British Rubber Manufacturers Association Ltd. Broad Rental Market Area (UK) Brokers and Reinsurance Markets Association Blue Ridge Mountains Arts Association

Samples in periodicals archive:

The post-mortem team should meet on a scheduled basis, probably associated with a quarterly business review, but separate from any all-encompassing business review meeting.

Covert money losses in outsourcing: understanding the less obvious ...

Sharer's self-assured style was present at a recent business review meeting in Hollywood.

BOSS' PAY GROWS WITH AMGEN

Bring the right people into the loop: Ideally, says Lester, a business review meeting should be conducted among high-level participants who have the authority to solve problems and make "forward-thinking" strategic decisions.

Sales: the key account business review

Fisher HealthCare Account Management Teams will provide periodic full-range business review meetings with AmeriNet Alliances that will also cover standardization opportunities, new suppliers and/or products, savings gained and future cost-savings opportunities.

AmeriNet and Fisher HealthCare Renew Agreement, Offer More Diverse ...

NEW YORK--(BUSINESS WIRE)--March 4, 1997--At its annual business review meeting, Amgen (NASDAQ:AMGN) today told the financial community that NEUPOGEN (R) (Filgrastim) and EPOGEN (R) (Epoetin alfa) are delivering solid sales growth that will continue to enhance shareholder value and feed a growing research and development program.

Amgen updates financial community on clinical progress and new ...